Isocyclosporin A clinical trials

A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel Group Study With 2 Weeks of Follow-Up to Evaluate Safety and Efficacy of Two Different Dosages of Isocyclosporin A Eye Drop Solution Versus Vehicle in Adult Patients with Atopic Keratoconjunctivitis (AKC).

This study is testing a new eye drop called Isocyclosporin A for adults with a severe allergic eye condition called Atopic Keratoconjunctivitis (AKC). It aims to see if the drops can reduce itchy eyes and are safe to use.